Focus on Diabetes

missing image

ReachMD takes an in-depth look at diabetes, a disease identified in nearly 1 in 10 Americans, which upsets the lives of millions more. Even more disturbing, the rates of new cases of diagnosed diabetes have risen almost twofold during the past decade. Nutrition, exercise and genetics are all factors in how the disease affects children, adults and the elderly, but that's only the beginning. How are surgical options changing the way we think about the disease? How close are we to a cure for Type 1 diabetes? Are there treatment lessons we can take from community-based initiatives abroad? Tune in to gain insights for your practice.

0 Likes     0 Followers     1 Subscribers

Sign up / Log in to like, follow, recommend and subscribe!

Website
http://reachmd.com/programs/focus-on-diabetes/
Description
ReachMD takes an in-depth look at diabetes, a disease identified in nearly 1 in 10 Americans, which upsets the lives of millions more. Even more disturbing, the rates of new cases of diagnosed diabetes have risen almost twofold during the past decade. Nutrition, exercise and genetics are all factors in how the disease affects children, adults and the elderly, but that's only the beginning. How are surgical options changing the way we think about the disease? How close are we to a cure for Type 1 diabetes? Are there treatment lessons we can take from community-based initiatives abroad? Tune in to gain insights for your practice.
Language
🇬🇧 English
last modified
2018-10-18 10:50
last episode published
2015-08-31 04:00
Contributors
ReachMD owner   author  
Explicit
false
Number of Episodes
85
Rss-Feeds
Detail page
Categories
Science & Medicine Health Medicine

Recommendations


Episodes

Date Thumb Title & Description Contributors
15.10.2018

When Insulin Isn’t Enough: Exploring Dual SGLT1 and SGLT2 Inhibition in T1DM

Host: Shira Johnson, MD Guest: Anne Peters, MD Guest: Donna Miller, MSN, FNP-C, CDE Guest: Jana Conley This activity explores new and emerging treatments for type 1 diabetes, including a dual sodium glucose transporter 1/2 inhibitor, and provid...
25.09.2018

The P4 Approach: Predictive, Preventive, Personalized and Participatory Medicine

Host: Rishi P. Singh, MD Guest: Arshad Khanani, MD Guest: Ehud Ur, MD Guest: David Boyer, MD Therapeutic options for the treatment of DR and DME have expanded, and advancements in medical imaging technologies provide a wider scope of options fo...
5.03.2018

Is a Low-Carb High-Fat Diet the Key to Diabetic Management?

Host: Barnett Mennen, MD Guest: Sarah Hallberg, MD Carbohydrates are our main source of energy and provide important nutrients for good health. However, they are also the main culprit behind elevated blood sugar and are problematic for diabetic pat...
5.03.2018

Is a Low-Carb High-Fat Diet the Key to Diabetic Management?

Host: Barnett Mennen, MD Guest: Sarah Hallberg, MD Carbohydrates are our main source of energy and provide important nutrients for good health. However, they are also the main culprit behind elevated blood sugar and are problematic for diabetic pat...
28.02.2018

Diabetes and Cardiovascular Risk: New Thinking, New Opportunities

Host: John J. Russell, MD Guest: John (Jack) L. Leahy, MD Diabetes is a major global health emergency, affecting approximately 415 million adults and contributing to five million deaths each year. Cardiovascular disease is a serious complication of...
28.02.2018

Diabetes and Cardiovascular Risk: New Thinking, New Opportunities

Host: John J. Russell, MD Guest: John (Jack) L. Leahy, MD Diabetes is a major global health emergency, affecting approximately 415 million adults and contributing to five million deaths each year. Cardiovascular disease is a serious complication of...
23.01.2018

Improving Glycemic Control: Reducing Patient Burden, The Rationale for Concentrated Insulins in Type 2 Diabetes Mellitus

Host: John J. Russell, MD Guest: Anne Peters, MD, CDE Many patients with type 2 diabetes mellitus cannot be controlled with standard insulin agents due to obesity, insulin resistance, high risk of hypoglycemia, low adherence due to high injection b...
23.01.2018

Improving Glycemic Control: Reducing Patient Burden, The Rationale for Concentrated Insulins in Type 2 Diabetes Mellitus

Host: John J. Russell, MD Guest: Anne Peters, MD, CDE Many patients with type 2 diabetes mellitus cannot be controlled with standard insulin agents due to obesity, insulin resistance, high risk of hypoglycemia, low adherence due to high injection b...
28.11.2017

Enhancing Adherence to Maintain Glycemic Control in Patients with Type 2 Diabetes

Host: Matt T. Rosenberg, MD Guest: Monica E. Peek, MD, MPH, MSC Attaining and maintaining glycemic control continues to be very difficult for patients with type 2 diabetes. Please join Drs. Matt T. Rosenberg and Monica E. Peek as they discuss these...
28.11.2017

Enhancing Adherence to Maintain Glycemic Control in Patients with Type 2 Diabetes

Host: Matt T. Rosenberg, MD Guest: Monica E. Peek, MD, MPH, MSC Attaining and maintaining glycemic control continues to be very difficult for patients with type 2 diabetes. Please join Drs. Matt T. Rosenberg and Monica E. Peek as they discuss these...
26.05.2017

FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin

Based on new data from two large clinical trials, the FDA concluded that the type 2 diabetes medicine canagliflozin (brand names Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. The FDA is requiring new warnings,...
16.05.2017

FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin

Based on new data from two large clinical trials, the FDA concluded that the type 2 diabetes medicine canagliflozin (brand names Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. The FDA is requiring new warnings,...
16.05.2017

FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin

Based on new data from two large clinical trials, the FDA concluded that the type 2 diabetes medicine canagliflozin (brand names Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. The FDA is requiring new warnings,...
15.05.2017

What is the Rationale for Fixed-Ratio Combinations of Basal Insulin Analogs and GLP-1 Receptor Agonists?

Host: John J. Russell, MD Guest: Wendy S. Lane, MD In this interview, Dr. Lane will review the clinical evidence supporting combinations of GLP-1 receptor agonists with basal insulin for the treatment of type 2 diabetes.
15.05.2017

What is the Rationale for Fixed-Ratio Combinations of Basal Insulin Analogs and GLP-1 Receptor Agonists?

Host: John J. Russell, MD Guest: Wendy S. Lane, MD In this interview, Dr. Lane will review the clinical evidence supporting combinations of GLP-1 receptor agonists with basal insulin for the treatment of type 2 diabetes.
15.05.2017

How Fixed-Ratio Combinations Are Individualizing Type 2 Diabetes Treatment

Host: Jennifer Caudle, DO Guest: Javier Morales, MD, FACP, FACE In this case-based discussion, Dr. Morales will share insights from his clinical experience on selecting patients likely to benefit from treatment with fixed-ratio combinations of GLP-...
15.05.2017

How Fixed-Ratio Combinations Are Individualizing Type 2 Diabetes Treatment

Host: Jennifer Caudle, DO Guest: Javier Morales, MD, FACP, FACE In this case-based discussion, Dr. Morales will share insights from his clinical experience on selecting patients likely to benefit from treatment with fixed-ratio combinations of GLP-...
15.05.2017

How to Administer Fixed-Ratio Combinations of GLP-1 Receptor Agonists & Basal Insulin

Host: Matt Birnholz, MD Guest: Javier Morales, MD, FACP, FACE Guest: Wendy S. Lane, MD Demonstration and Panel Discussion: We will present video demonstrations of how to administer fixed-ratio combinations of GLP-1 receptor agonists and basal ins...
15.05.2017

How to Administer Fixed-Ratio Combinations of GLP-1 Receptor Agonists & Basal Insulin

Host: Matt Birnholz, MD Guest: Javier Morales, MD, FACP, FACE Guest: Wendy S. Lane, MD Demonstration and Panel Discussion: We will present video demonstrations of how to administer fixed-ratio combinations of GLP-1 receptor agonists and basal ins...
19.12.2016

The Rising Diabulimia Epidemic: Safeguarding Diabetic Patients with Eating Disorders

Host: Brian P. McDonough, MD, FAAFP Diabulimia, defined as the manipulation of insulin treatments by Type 1 diabetic patients in order to lose weight, is a rising problem among teens and young adults in the U.S, particularly young women. Joining Dr. B...
19.12.2016

The Rising Diabulimia Epidemic: Safeguarding Diabetic Patients with Eating Disorders

Host: Brian P. McDonough, MD, FAAFP Diabulimia, defined as the manipulation of insulin treatments by Type 1 diabetic patients in order to lose weight, is a rising problem among teens and young adults in the U.S, particularly young women. Joining Dr. ...
15.12.2016

Optimizing Outcomes in Diabetic Retinopathy: Improving Screening, Referral, and Treatment

Host: Matt Birnholz, MD Guest: Rishi P. Singh, MD The past 40 years have witnessed great advancements in therapeutic options for treating diabetic retinopathy. Despite a number of effective treatment options, diabetic eye disease is one of the lead...
15.12.2016

Optimizing Outcomes in Diabetic Retinopathy: Improving Screening, Referral, and Treatment

Host: Matt Birnholz, MD Guest: Rishi P. Singh, MD The past 40 years have witnessed great advancements in therapeutic options for treating diabetic retinopathy. Despite a number of effective treatment options, diabetic eye disease is one of the leadin...
30.05.2016

Rates of Obesity and Diabetes Lower in More Walkable Neighborhoods

[Read the Article] Despite targeted efforts to reduce obesity through diet and exercise, these rates continue to rise. A new study from Ontario, Canada found that obesity and diabetes rates were lower in more walkable neighborhoods compared to less wal...
30.05.2016

Rates of Obesity and Diabetes Lower in More Walkable Neighborhoods

[Read the Article] Despite targeted efforts to reduce obesity through diet and exercise, these rates continue to rise. A new study from Ontario, Canada found that obesity and diabetes rates were lower in more walkable neighborhoods compared to less wal...
30.11.2015

Diabetes Research Suggests Better Long Term Outcomes with Early Insulin

Host: Jennifer Caudle, DO Host Jennifer Caudel, DO wlecomes Jay Shubrook, DO, Director of Clinical Research and Diabetes Services at Touro University-California College of Osteopathic Medicine. Recorded on site at the American Osteopathic Association'...
30.11.2015

Diabetes Research Suggests Better Long Term Outcomes with Early Insulin

Host: Jennifer Caudle, DO Host Jennifer Caudel, DO welcomes Jay Shubrook, DO, Director of Clinical Research and Diabetes Services at Touro University-California College of Osteopathic Medicine. Recorded on site at the American Osteopathic Association...
25.11.2015

Injectable Medication as an Alternative Treatment for Diabetic Eye Disease

[Read the Article] Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss in patients with diabetes, resulting in up to 24,000 cases of blindness each year in the United States. Laser therapy has been the most common treatment used ...
25.11.2015

Injectable Medication as an Alternative Treatment for Diabetic Eye Disease

[Read the Article] Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss in patients with diabetes, resulting in up to 24,000 cases of blindness each year in the United States. Laser therapy has been the most common treatment used ...
31.08.2015

The Role of the Certified Diabetes Educator: A Team Effort

Host: John J. Russell, MD Guest: Candis Morello, PharmD, CDE Candis M Morello, Professor of Clinical Pharmacy at UC San Diego Skaggs School of Pharmacy& Pharmaceutical Sciences, joins Dr. John Russell to talk about team-based care integration...
31.08.2015

The Role of the Certified Diabetes Educator: A Team Effort

Host: John J. Russell, MD Guest: Candis Morello, PharmD, CDE Candis M Morello, Professor of Clinical Pharmacy at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, joins Dr. John Russell to talk about team-based care integrations o...
27.07.2015

Hot Topics in Diabetes: What Endocrinologists are Talking About

Host: Brian P. McDonough, MD, FAAFP Dr. Brian McDonough welcomes Dr. Tina Thethi, Assistant Professor of Medicine in the section of Endocrinology and Metabolism at Tulane University Health Sciences Center. Dr. Thethi provides the inside scoop on diab...
27.07.2015

Hot Topics in Diabetes: What Endocrinologists are Talking About

Host: Brian P. McDonough, MD, FAAFP Dr. Brian McDonough welcomes Dr. Tina Thethi, Assistant Professor of Medicine in the section of Endocrinology and Metabolism at Tulane University Health Sciences Center. Dr. Thethi provides the inside scoop on diabe...
2.11.2010

Regeneration of Insulin-Producing Islets in our Patients

Host: Bruce Bloom, DDS, JD Guest: G. Alexander Fleming, MD Researchers are looking at hundreds of ways to treat and cure type one diabetes. Most of the advances so far have come in newly diagnosed children. Is there anything on the horizon to help ...
2.11.2010

Regeneration of Insulin-Producing Islets in our Patients

Host: Bruce Bloom, DDS, JD Guest: G. Alexander Fleming, MD Researchers are looking at hundreds of ways to treat and cure type one diabetes. Most of the advances so far have come in newly diagnosed children. Is there anything on the horizon to help ad...
1.11.2010

Biomolecular Advances in Diabetes Prevention

Host: Bruce Bloom, DDS, JD Guest: Carmella Evans-Molina, MD, PhD As the epidemic of type 2 diabetes in the United States grows, researchers are investigating hundreds of ways to treat and cure diabetes. Some of these methods include exogenous insul...
1.11.2010

Biomolecular Advances in Diabetes Prevention

Host: Bruce Bloom, DDS, JD Guest: Carmella Evans-Molina, MD, PhD As the epidemic of type 2 diabetes in the United States grows, researchers are investigating hundreds of ways to treat and cure diabetes. Some of these methods include exogenous insulin...
29.10.2010

Cardiac Screening for Asymptomatic Patients With Diabetes

Host: Lee Freedman, MD Guest: Steven Wittlin, MD It is often thought that patients with diabetes have more "silent" heart disease than patients without diabetes: Coronary artery disease is a leading cause of death among these patients. But is scree...
29.10.2010

Cardiac Screening for Asymptomatic Patients With Diabetes

Host: Lee Freedman, MD Guest: Steven Wittlin, MD It is often thought that patients with diabetes have more"silent" heart disease than patients without diabetes: Coronary artery disease is a leading cause of death among these patients. But is screenin...
28.10.2010

Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression

Host: Mary Leuchars, MD Guest: Christopher Slatore, MD Systemic corticosteroids increase the risk of diabetes, but what about in patients who take high-dose inhaled corticosteroids? How do we best manage the risk-benefit equation in patients with chr...
28.10.2010

Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression

Host: Mary Leuchars, MD Guest: Christopher Slatore, MD Systemic corticosteroids increase the risk of diabetes, but what about in patients who take high-dose inhaled corticosteroids? How do we best manage the risk-benefit equation in patients with c...
28.10.2010

The Hygiene Hypothesis and Risk of Type 1 Diabetes in Children

Host: Mary Leuchars, MD Guest: Carolyn Paris, MD Improved living conditions and hygiene may be contributing to the rise of type 1 diabetes in children, but does the "hygiene hypothesis" fully explain the onset of type 1 diabetes in this population?...
28.10.2010

The Hygiene Hypothesis and Risk of Type 1 Diabetes in Children

Host: Mary Leuchars, MD Guest: Carolyn Paris, MD Improved living conditions and hygiene may be contributing to the rise of type 1 diabetes in children, but does the"hygiene hypothesis" fully explain the onset of type 1 diabetes in this population? Wh...
26.10.2010

Weighing Metformin's Benefits& Risks in Patients With Renal Insufficiency

Host: Lee Freedman, MD Guest: Hugh Tildesley, MD Metformin is often the first line of therapy for patients with type 2 diabetes: it is relatively inexpensive, available, and has proven efficacy. However, metformin is contraindicated for patients with...
26.10.2010

Weighing Metformin's Benefits & Risks in Patients With Renal Insufficiency

Host: Lee Freedman, MD Guest: Hugh Tildesley, MD Metformin is often the first line of therapy for patients with type 2 diabetes: it is relatively inexpensive, available, and has proven efficacy. However, metformin is contraindicated for patients wi...
20.10.2010

The Cost of Diabetes to the Healthcare System

Host: Bruce Japsen Guest: Joanna Jiang, MD The new health reform law will take steps to encourage patients to use preventive tests and screenings to head off chronic conditions, like diabetes, that extract a huge toll on the nation's medical care bud...
20.10.2010

The Cost of Diabetes to the Healthcare System

Host: Bruce Japsen Guest: Joanna Jiang, MD The new health reform law will take steps to encourage patients to use preventive tests and screenings to head off chronic conditions, like diabetes, that extract a huge toll on the nation's medical care b...
18.10.2010

Clinical Limitations of the Metabolic Syndrome: Do We Need to Redefine the Concept?

Host: Maurice Pickard, MD Guest: Gerald Reaven, MD Metabolic syndrome is generally considered to be a combination of conditions that increases a patient's risk of developing coronary artery disease. These conditions include elevated blood pressure, o...
18.10.2010

Clinical Limitations of the Metabolic Syndrome: Do We Need to Redefine the Concept?

Host: Maurice Pickard, MD Guest: Gerald Reaven, MD Metabolic syndrome is generally considered to be a combination of conditions that increases a patient's risk of developing coronary artery disease. These conditions include elevated blood pressure,...
14.10.2010

How Technology is Improving Care for Patients With Diabetes

Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA Guest: Adam Weinstein With Web-based technologies, the click of a mouse can give doctors and advanced practice clinicians access to their diabetic patients' records follow-up information, and save...